← peptides typeshit

HSE Drugs Group weighs Mounjaro but makes no recommendation yet

RTÉ reports Lilly's new pricing offer would cost Ireland about €2 to €3 billion a year if offered publicly. A Wegovy cost assessment is due soon.

Read at RTE.ie

Recap by typeshit. Full story at RTE.ie.